GLOBUS Financial Statements From 2010 to 2024
| GM0N Stock | EUR 79.50 1.00 1.24% |
Check GLOBUS MEDICAL-A financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GLOBUS MEDICAL-A's main balance sheet or income statement drivers, such as , as well as many indicators such as . GLOBUS financial statements analysis is a perfect complement when working with GLOBUS MEDICAL-A Valuation or Volatility modules.
GLOBUS |
GLOBUS MEDICAL A Company Price To Sales Analysis
GLOBUS MEDICAL-A's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current GLOBUS MEDICAL-A Price To Sales | 7.57 X |
Most of GLOBUS MEDICAL-A's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GLOBUS MEDICAL A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, GLOBUS MEDICAL A has a Price To Sales of 7.5678 times. This is much higher than that of the sector and significantly higher than that of the Other industry. The price to sales for all Germany stocks is notably lower than that of the firm.
GLOBUS MEDICAL A Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GLOBUS MEDICAL-A's current stock value. Our valuation model uses many indicators to compare GLOBUS MEDICAL-A value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GLOBUS MEDICAL-A competition to find correlations between indicators driving GLOBUS MEDICAL-A's intrinsic value. More Info.GLOBUS MEDICAL A is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for GLOBUS MEDICAL A is about 1,607,175,974 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GLOBUS MEDICAL-A's earnings, one of the primary drivers of an investment's value.About GLOBUS MEDICAL-A Financial Statements
GLOBUS MEDICAL-A stakeholders use historical fundamental indicators, such as GLOBUS MEDICAL-A's revenue or net income, to determine how well the company is positioned to perform in the future. Although GLOBUS MEDICAL-A investors may analyze each financial statement separately, they are all interrelated. For example, changes in GLOBUS MEDICAL-A's assets and liabilities are reflected in the revenues and expenses on GLOBUS MEDICAL-A's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GLOBUS MEDICAL A. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL-A financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL-A security.